Fresenius SE & Co. KGaA/ DE0005785604 /
6/6/2025 6:11:53 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
50.2900USD | - | 2,246 Turnover: 105,323.9250 |
-Bid Size: - | -Ask Size: - | 27.25 bill.USD | - | - |
GlobeNewswire
3/18
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Acc...
GlobeNewswire
4/23/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
2/23/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
9/4/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
8/31/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil